Reaction

Erythroleukaemia reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 75 reports · 2 co-occurring drugs

As of the last recalculation, Erythroleukaemia appears in 75 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is CLADRIBINE (PRR 222.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Cladribine7222.8223.0
Azacitidine10107.8107.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.